RethinkTHC Search
Menu
Study breakdown

Cannabis Terpenes Directly Activate Cannabinoid Receptors, Supporting the Entourage Effect

Animal StudyModerate evidence
The takeaway

Sixteen cannabis terpenes selectively activated CB1 and CB2 receptors at concentrations equal to or lower than THC, with different terpenes showing different receptor preferences.

Cannabis scientists, terpene researchers, and anyone interested in the entourage effect and cannabis strain differences.

Terpenes: lower efficacy but equal or better potency than THC

What the researchers found

Multiple cannabis terpenes produced dose-dependent activation of both CB1 and CB2 receptors, reaching 10-60% of THC's maximal activation. Terpenes showed lower efficacy but equivalent or even improved potency compared to THC. At CB2, multiple terpenes reached clinically relevant effect levels at concentrations equal to or lower than THC. Different terpenes showed selectivity between the two receptors.

Why it matters

This provides direct molecular evidence for the "entourage effect" hypothesis. Terpenes are not just aroma compounds; they are partial agonists at the same receptors THC targets. Their selectivity between CB1 and CB2 means different terpene profiles could produce different therapeutic effects.

The numbers in context

16 cannabis terpenes tested. Activation: 10-60% of THC maximal response. EC50 values similar to or lower than THC. At CB2, multiple terpenes reach clinically relevant concentrations (0.1 micromolar or above).

How the study worked

Xenopus oocyte functional expression system measuring GIRK currents as a readout for CB1 and CB2 receptor activation by 16 individual cannabis terpenes and terpene mixtures.

What this study cannot tell us

In vitro expression system may not perfectly replicate receptor activation in the brain. Terpene concentrations achievable in the brain after cannabis consumption are uncertain. Functional significance of 10-60% activation relative to THC needs further investigation.

How to read the evidence

Published in Biochemical Pharmacology with rigorous in vitro receptor pharmacology, but translation to in vivo effects remains uncertain.

When this study was published

2026 study.

The bigger picture

The cannabis industry has long marketed different strains by their terpene profiles, but the scientific evidence for terpenes having cannabinoid activity has been limited. This study strengthens the case that terpene composition meaningfully affects the pharmacological profile of cannabis products.

Questions still open

  • Can terpene profiles be optimized for specific therapeutic outcomes? Do different cannabis strains produce meaningfully different effects based on their terpene composition?

Common questions

Do terpenes actually do anything pharmacologically?
Yes. This study shows 16 cannabis terpenes directly activate the same CB1 and CB2 receptors as THC, though at lower efficacy. Different terpenes show different receptor preferences.
What does this mean for the entourage effect?
It provides molecular evidence that terpenes contribute pharmacological activity beyond just aroma, supporting the idea that whole-plant cannabis may have different effects than pure THC alone.

Read the original research

Selective activation of cannabinoid receptors by cannabis terpenes.

Biochemical pharmacology, 243(Pt 1), 117498

Citation

Raz, Noa; Eyal, Aharon M; Fahoum-Khalefa, Nardine; Tauber, Merav; Ben-Chaim, Yair. (2026). Selective activation of cannabinoid receptors by cannabis terpenes.. Biochemical pharmacology, 243(Pt 1), 117498. https://doi.org/10.1016/j.bcp.2025.117498

Explore the wider topic